TrialAmerican journal of clinical oncology2011

Dual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancer.

Emily Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.